Authors: Philip Anglewicz, Pierre Akilimali, Georges Guiella, Patrick Kayembe, Simon P. S. Kibira, Fredrick Makumbi, Amy Tsui, & Scott Radloff
Journal: Contraception: X, 1. November 2019
Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is seen as a valuable innovation in family planning, but little is known about trends in DMPA-SC use or characteristics of users. Using data from Burkina Faso, the Democratic Republic of Congo (DRC) and Uganda, we measured trends in DMPA-SC and identified characteristics associated with DMPA-SC use.